Close
Nordic 9Nordic 9

Freeman Road (investor - Private Equity)

Australia
See something wrong or missing? Let us know

Freeman Road is a boutique investment group specializing in Health and Technology focusing on early-stage companies

Average round investment:12.55M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Finland Valo Therapeutics
Mostly invests in: Finland Finland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Freeman Road

Name Criteria
United Kingdom Advent Life Sciences
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Australia MMJ Group Holdings
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Ilmarinen
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Bosch Ventures
72%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Germany SHS Capital
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Finland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Italy AurorA Science
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Essential Investments
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Future Ventures
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Jaquet Partners
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top